EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lentinula edodes as a Source of Bioactive Compounds with Therapeutical Potential in Intestinal Inflammation and Colorectal Cancer

Mikołaj Bugajewski, Norbert Angerhoefer iD, Leszek Pączek, Beata Kaleta iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073320 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mikołaj Bugajewski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Students Scientific Society, Department of Clinical Immunology, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland. Hauptthemen laut MEDLINE: Shiitake Mushrooms, Colorectal Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a rising global health issue. Chronic intestinal inflammation is an important risk factor for colorectal cancer (CRC). Despite significant progress in IBD and CRC treatment, numerous patients remain resistant to standard pharmacotherapy or experience severe side effects that prevent them from continuing treatment. There is evidence suggesting that bioactive substances in Lentinula edodes have immunomodulatory and anticancer properties. This fungus is currently classified as a functional food, considering its beneficial effects on human health and special nutritional value. Studies conducted in vitro and in animal models demonstrated that L. edodes bioactive compounds, in particular glucans, have anti-inflammatory and antioxidant effects, induce apoptosis of cancer cells, reduce tumor angiogenesis, restore gut microbiome heterogeneity and improve gut barrier dysfunction. Moreover, clinical trials confirmed that these compounds combined with standard chemotherapy have a significant effect in improving the prognosis of CRC patients. In addition, L. edodes glucans increase microbial diversity and enhance interferon (IFN)-γ production by immune cells. Future studies must be focused on understanding the pathways and mechanisms associated with the observed effects. Moreover, both randomized trials and long-term follow-up studies are needed to confirm their effectiveness in the treatment of IBD and CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shiitake MushroomsColorectal NeoplasmsInflammatory Bowel DiseasesHumansAnimalsGastrointestinal MicrobiomeAntineoplastic AgentsAnti-Inflammatory Agents

Stichwörter der Autor:innen

Crohn’s diseaseLentinula edodescolorectal cancerfunctional foodgutinflammatory bowel diseaseulcerative colitis

Substanzen

Antineoplastic AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Students Scientific Society, Department of Clinical Immunology, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland.
  • Department of Clinical Immunology, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland.
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, 02-106 Warsaw, Poland.

ORCID-Profile: Norbert Angerhoefer, Beata Kaleta

Zitieren

APA

Bugajewski, M., Angerhoefer, N., Pączek, L., & Kaleta, B. (2025). Lentinula edodes as a Source of Bioactive Compounds with Therapeutical Potential in Intestinal Inflammation and Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073320

Vancouver

Bugajewski M, Angerhoefer N, Pączek L, Kaleta B. Lentinula edodes as a Source of Bioactive Compounds with Therapeutical Potential in Intestinal Inflammation and Colorectal Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073320

BibTeX
@article{Bugajewski2025,
  author = {Bugajewski, Mikołaj and Angerhoefer, Norbert and Pączek, Leszek and Kaleta, Beata},
  title = {Lentinula edodes as a Source of Bioactive Compounds with Therapeutical Potential in Intestinal Inflammation and Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073320}
}
Kostenlos starten →